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BACKGROUND: Nigeria is the second largest country with 
paediatric HIV infections. Mother to Child transmission of HIV 
remains a major source of paediatric infection in Nigeria. This 
study was conducted to determine the outcomes of HIV exposed 
infants in selected Primary Health Care Centres. 
 METHODS: A retrospective cohort study on HIV exposed infants 
between January 2015 to July 2016. A proforma was used to 
abstract information from clinic records on socio-demographics 
characteristics, ARV prophylaxis, mode of delivery, birth weight, 
infant prophylaxis, early infant diagnosis (EID), referral to ART. 
Descriptive and multivariate analysis was done to determine 
predictors of HIV infection among exposed infants. 
 RESULTS: 170 exposed infants were recruited, and more than 
two-third of the infants were males (74.1%) with median age 
4±3months ranging from (0 -11months). One hundred and fifty 
(88.2%) received infant prophylaxis and 116 (68.2%) had EID 
done at 6weeks. Of the 170 exposed infants 19(11.1%) were positive 
at 18months. Predictors of HIV infection were age of mothers 
≥30years (Adjusted Odd’s Ratio = 2.5,95%CI 1.9 – 16.93), Vaginal 
tear (Adjusted OR= 2.7,95%CI 2.1- 19.21), infants whose maternal 
CD4 count < 500(Adjusted OR= 3.5,95%CI 1.7 -15.02) and infant 
received prophylaxis other than daily Nevirapine for 6weeks 
(Adjusted OR=3.0,95%CI 2.4-12.74). 
CONCLUSION: The positivity rate among studied exposed infants 
was high. Continuous placement of younger HIV positive mothers 
and exposed infants on recommended prophylaxis and timely early 
infant diagnosis will go a long way in reducing the burden of 
paediatric HIV. 





Nigeria is the second largest country with burden of HIV in the 
world, and around two-thirds of new HIV infections in the African 
region in 2017 occurred in Nigeria (1). In 2018,130,000, new HIV 
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infections and 53 000 AIDS-related deaths 
occurred in Nigeria, and 1,900, 000 people were 
living with HIV. Among these55% were on 
treatment, while only 35% of children aged 0–14 
years living with HIV were on treatment (2).  
Among pregnant women living with HIV, 44% 
accessed antiretroviral medicine to prevent 
transmission of the virus to their baby, 
preventing 7200 new HIV infections among 
newborns. Early infant diagnosis―the 
percentage of HIV-exposed infants tested for 
HIV before eight weeks of age―stood at 18% in 
2018(2).  
The UNAIDS Catch-Up Plan for West and 
Central Africa, outlines a target to enrol an 
additional 140,000 children across the region on 
ART by 2020 (3).  Reducing mother-to-child 
transmission remains a major target area, and 
Nigeria was selected as one of UNAIDS’ 23 
priority countries for PMTCT – being one of the 
nations with the highest HIV burden yet low 
levels of treatment coverage during pregnancy. 
Of these 23 countries, Nigeria has the second 
lowest level of ART coverage in pregnant 
women (4).  
The numbers of children and young 
adults becoming infected with HIV and dying 
from AIDS is probably going to remain high, 
unless the HIV response – both prevention and 
treatment – improves significantly (5). The 
number of pregnant women visiting health 
facilities remains low, as does the number of 
health facilities providing PMTCT services, with 
only 7,265 health facilities providing PMTCT in 
2015(6). Nigeria’s major drawback is that 25% 
of women give birth at home or in birth homes 
run by traditional birth attendants, where women 
are unlikely to get tested for HIV (7).  Despite 
national commitments to attain universal access 
to HIV prevention, treatment, care and support, 
many people still do not have access to the HIV 
services needed, especially in poor, rural areas 
who are majorly served by primary healthcare 
facilities. Regular HIV testing, treatment and 
care for children with HIV/AIDS can enable 
them to live long and have fulfilling lives. 
However, an absence of necessary investment 
and resources for adequate testing, pediatrics 
ARVs and children-oriented prevention 
programmes may make the children more prone 
to  the consequences of the epidemic. 
"Primary Health Care is essential health care 
based on practical, scientifically sound and 
socially acceptable methods and technology, 
made universally accessible to individuals and 
families in the community through their full 
participation and at a cost that the community 
and the country can afford to maintain at every 
stage of their development in the spirit of self-
reliance and self-determination" (8). Essential 
health services that should be available at 
primary healthcare facilities in relation to HIV 
and AIDs are voluntary counselling and testing 
(VCT), basic HIV prevention and treatment for 
simple opportunistic infections; the provision of 
other HIV services at primary healthcare level, 
such as anti-retroviral treatment and treatment 
for complicated opportunistic infections.  
Primary healthcare facilities should provide 
clear, efficient and effective referrals to higher 
levels of the health system for all HIV services 
not available, including the provision of more 
complex services, such as viral load testing. A 
primary healthcare (PHC) approach is generally 
considered as being central to providing 
equitable healthcare (9). The decentralization of 
care includes the provision of HIV care and 
treatment such as antiretroviral therapy, both in 
PHC clinics and within communities (10). It has 
been found that the integration of HIV care and 
treatment services in primary healthcare benefit 
the larger PHC system (11). Decentralization of 
HIV/AIDS services requires the expansion of 
HIV management programs including ART and 
PMTCT to a greater scale, with an emphasis on 
increasing utilization to improve the quality of 
life for a significant number of people living 
with HIV and AIDS (PLWHA) and HIV-
positive pregnant women (12). Nigeria’s 
population is served by a three-tier health 
service delivery system (primary, secondary and 
tertiary) of public and private facilities. 
Currently, most HIV/AIDS services are 
provided in the secondary and tertiary facilities 
managed by the public sector, which attracts 
most of Nigeria’s health resources including 
qualified staff (12). This study was conducted to 
determine outcome of HIV exposed infants and 
identify predictors for this outcome in selected 
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MATERIALS AND METHODS 
 
Study area: Ibadan is the capital and most 
populous city of Oyo State, Nigeria. With an 
estimated population of 3million, it is the third 
most populous city 
in Nigeria after Lagos and Kano (13). According 
to NACA, 200,000 persons in Oyo State are 
living with the Human Immuno-Deficiency 
Virus (HIV) and the dreaded Acquired Immune 
Deficiency Syndrome (AIDS), and only eight 
per cent of the affected persons were receiving 
treatment. About 10,000 expectant mothers in 
Oyo State are living with HIV, and about 50 
people contact HIV in the state daily (1). There 
are twenty-one government owned health 
facilities in Ibadan offering PMTCT services 
(14). This was a retrospective cohort study 
conducted from April to May 2018. 
Participants for this study were mother-
child pairs registered in selected PMTCT clinics 
from 1st January 2015 to July 31St, 2016. 
Medical records of HIV-exposed infants and 
their mothers enrolled into the program were 
reviewed for study inclusion. To determine the 
sample size, a post-hoc sample size calculation 
was used with the following parameters: 
prevalence of HIV among pregnant women 
in Oyo state was 1.9% (15), prevalence of 
HIV among HIV exposed infants 8.7% (16), 
power of 80%, 95% confidence interval and 
enrolment ratio of 1. The minimum sample 
size calculated was 169 for mother-infant 
pairs and was rounded up to 170.  
Sampling Technique: A Two-stage sampling 
technique was used: 
Stage 1: The list of all the Primary Health Care 
Centers (PHCs) offering PMTCT services in 
Ibadan was obtained. Of the eligible facilities, 
14 was selected using simple random sampling.  
Stage 2: A list of HIV positive mothers enrolled 
in each PMTCT clinics was obtained. Records 
of HIV mother-infant pair between 2015 and 
2016 were obtained from each facility, and the 
sum of client load in the 14 facilities was used as 
the sampling frame. Records were selected 
proportionately and allocated based on patients’ 
load from each facility. Mother-infant pairs were 
selected using systematic sampling (the first 
mother-infant pair in each clinic was randomly 
selected afterwards every 2nd mother-infant pair 
was selected for the interview) until the desired 
sample size per facility was obtained.  
 
Study variables: The dependent variable (main 
outcome) was HIV status of the exposed infants 
(infected, not infected). HIV status was 
determined using results from the 1st PCR and 
2nd PCR tests as well as rapid HIV test 18 
months of age. While the independent variables 
were categorized as maternal and infant factors. 
Maternal factors included mother’s age, 
educational status, marital status, occupational 
status, religion, mode of delivery ARV 
prophylaxis during ANC, labour and delivery, 
disclosure of HIV status, type of ARV, 
counseled on infant feeding options, place of 
delivery, mode of delivery, antenatal care visits, 
gestational age at first antenatal care visit, CD4 
count, WHO clinical stage at enrollment. Infant 
factors included age of infant enrollment at the 
PHC, birth weight, early infant diagnosis done at 
6 weeks, receipt of infant prophylaxis and infant 
feeding option. 
Training of research assistants and pre-test of 
data collection tools: Four research assistants 
were trained for four days by the principal 
investigator on the objectives of the study, data 
abstraction techniques and how to fill the 
proforma using android phones. During training, 
the importance of maintaining patient 
confidentiality was emphasized.  
Pre-testing of the data collection tools was 
done in St Anne’s Hospital, Molete, which is not 
part of the selected PMTCT clinics. The data 
collection tools and proforma were  pre-tested 
on fifteen mother-infant pair records. 
Appropriate corrections were done after 
analyzing the pre-test result and before the 
actual data collection. Sections which were 
inconsistent, invalid and poorly constructed 
were reviewed and corrected.   
Data collection and instrument: Data was 
abstracted by four trained research assistants and 
the investigator using android phones with Open 
Data kit. The data collection instrument was 
divided into four sections namely; facility 
information, ANC data, HIV diagnosis and ARV 
data and child data.  
Data analysis: The filled proforma were 
checked for completeness and the fields were 
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checked and validated before analysis. The 
primary outcome variable was categorized as 
“0” for HIV-negative and “1” for HIV-positive. 
HIV positivity rate among exposed infants was 
calculated as the number of HIV-positive infants 
divided by the total number exposed who 
received their final HIV test results. Final infant 
HIV status was determined by either a PCR or 
rapid HIV test as appropriate to infant’s age and 
infant feeding option. The HIV test was 
considered final if the PCR was done before 18 
months of age but six weeks after cessation of 
breast feeding or a rapid test done at 18 months 
of age but at least six weeks after stopping breast 
feeding. Descriptive statistics was computed 
using Epi-info Version 7.0 (17) to generate 
summary statistics. Frequency tables, charts, 
proportions and means were used to describe the 
data. 
Bivariate analyses were done to measure 
association between independent variables and 
HIV status of exposed infants using crude odd’s 
ratio. The p < 0.05 was used to determine level 
of statistical significance. Logistic regression 
model was fitted to identify factors determining 
the HIV status of exposed infants. 
Ethical consideration: Approval for the study 
was obtained from the Ethical Review 
Committee of Oyo State Ministry of Health 
(Approval number AD1349/547). To ensure 
confidentiality of any information provided, the 
data collection procedure was anonymous (no 
name was obtained). Data collection instruments 
were identified only from patients’ unique IDs 
and not by names. Study team members were 
trained on confidentiality of respondents’ data. 
While no personally identifiable information 
was collected, the abstractors saw patient names 
during the abstraction process. Thus, abstractors 
were required to sign a confidentiality 
agreement. Study electronic data was password 





Socio-demographic and health characteristics 
of HIV positive mothers: Table 1 shows the 
socio-demographic and health characteristics of 
HIV positive mothers. The mean age of the 
mothers was 31±3SD. Most of the mothers 
(85.3%) delivered at ≥36 weeks and a little more 
than half (57.6%) of them had CD4 count < 500 
copies per ml. The majority (84.7%) received 
ARV during the current pregnancy, and 66% 
were referred to ART clinic. 
 
Table 1: Socio-demographic and Health 
characteristics of HIV positive mothers in 




Age in years   
<20 11 6.4 
20-29 76 44.7 
30-39 68 40.0 
40-49 15 8.9 
Mean age 31 ± 3SD   
Gestational age at birth(weeks) 
  <36  25 14.7 
   ≥ 36 145 85.3 
Parity   
   0-2 122 71.8 
   3-5  48 28.2 
Mode of delivery   
   Vaginal 104 61.2 
   Emergency CS   19 11.2 
Elective CS 47 27.6 
Vaginal Tear   
   Yes 19 11.2 
    No 151 88.8 
CD4 Count   
    < 500 98 57.6 
    ≥ 500 46 27.1 
   Undocumented 26 15.3 
WHO Clinical Stage   
    1 79 46.7 
    2 50 29.6 
    3 20 11.8 
    4  5 3.0 
   Undocumented 17 8.9 
Received ARV during current pregnancy 
    Yes 144 84.7 
     No 10 5.9 
     Undocumented 16 9.4 
Type of ARV received(n=144) 
      LAD 17 21.9 
      Triple 123 72.2 
      Undocumented 4 5.9 
Referred to ARV   
     Yes 112 66.3 
      No 30 17.8 
 27 15.9 
Delivery Outcome   
     Alive 168 98.8 
     Dead 2 1.2 
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Infant socio and health characteristics: Table 
2 shows the socio-demographic and health 
characteristics of exposed infants. The median 
age of the infants was 4±3 months. Almost 
three-quarter (74.1%) of the infants were males, 
and the majority (91.2%) had birth weight ≥ 
2.5kg. Eighty-eight percent of the infants had 
ARV prophylaxis while 68.2% had early infant 
diagnosis done at 6 weeks.  
The positivity rate of exposed infants: Of the 
170 exposed infants studied, 19(11.1%) were 
found positive to HIV. 
Association between socio-demographic 
characteristics and infant outcomes: Table 3 
shows the association between socio-
demographic characteristics of mothers and 
infants in relation to infant outcomes. Mothers 
who were aged ≥30 years were more likely to 
have infants who will be infected with HIV, and 
infants with birth weight ≥ 2.5kg were less likely 
to be infected. Mothers who had ≥ 2children 
were 3 times more likely to have infant who will 






Table 2:  Infant Socio-demographic and Health 
Characteristics (n =170). 
 
Variable Frequency Percent 
Age(months)   
0-3 98 57.6 
4-6 32 18.9 
7-9 25 14.7 
≥10 15 8.8 
   Median age 4± 3   
Sex   
   Male 126 74.1 
   Female 44 25.9 
Birth Weight(Kg)   
    < 2.5 15 8.9 
    ≥ 2.5 155 91.1 
Received Prophylaxis   
    Yes 150 88.2 
    No 20 11.8 
EID done at 6 weeks   
    Yes 116 68.2 
     No 54 31.8 
Feeding Options at 3months   
    EBF 152 89.4 
    Formula Feeding 14 8.2 
    Mixed Feeding 5 2.9 
Referred to ART   
    Yes 15 78.9 
    No 4 21.1 
EBF means Exclusive Breastfeeding 
Table 3: Association between socio-demographic characteristics and infant outcomes 
 
Variable HIV infected(n=19) OR (95%CI) HIV uninfected(151) OR(95%CI) 
Age(years)     
< 30 5(26.4) 1 48(32.0) 1 
 ≥30 14(73.6) 1.8(1.52-11.93) 103(68.0) 1.5(0.98-11.28) 
Parity     
   < 2 6 (31.6) 1 53(35.3) 1 
   ≥ 2 13(68.4) 1.2(0.11-3.52) 98(64.7) 2.5(1.81-23.01) 
Marital Status     
    Single 3(15.8) 1 16(10.0) 1 
    Married 14(73.7) 0.4(0.14-13.21) 120(80.0) 2.8(0.34-5.29) 
   Others* 2(10.5) 0.5(0.15-2.18) 15(10.0) 1.3(0.28-3.53) 
Birth Weight(Kg)     
    < 2.5 2(10.5) 1 13(8.0) 1 
    ≥ 2.5 17(89.5) 0.2(0.01 -0.71) 138(92.0) 1.1(0.11-3.52) 
Sex of Infant     
    Male 8(42.1) 1 103(68.7) 1 
    Female 11(57.9) 0.5(0.16-1.94) 48(31.3) 1.8(0.29-7.20) 
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Association between health- related 
characteristics and infant outcomes: Table 4 
shows the association between health 
characteristics and infant outcomes. Mothers 
who delivered at gestational age ≥36 weeks were 
five times more likely to have infants who will 
be uninfected with HIV. Infants delivered 
through vaginal birth were five times more 
likely to be infected, and infants whose mothers 
had vaginal tear were four times more likely to 
be infected. 
 




AOR (95%CI) HIV uninfected(151) AOR(95%CI) 
Gestational age(weeks)     
 < 36 16(84.2) 1   25(16.7) 1 
 ≥36   3(15.8) 0.7 (0.06 -7.47) 126(83.3) 4.6(1.66-32.2) 
Delivery Outcome     
    Alive 17 (89.5) 1 141(93.4) 1 
    Dead   2(10.5) 0.3(0.01-4.21)   10(6.6) 2.3(0.18-5.40) 
Mode of Delivery     
    Elective CS 4(21.1) 1 128(85.3) 1 
    Vaginal birth 10(52.6) 5.2(2.69-31.04)   15(10.0) 1.0(0.44-3.29) 
    Emergency CS  5(26.3) 0.3(0.02-3.27)    8(4.7) 2.9(0.78-9.31) 
Vagina Tear     
    No 15(78.9) 1 137(90.7) 1 
    Yes  4(21.1) 3.7(2.5-10.21)   14(9.3) 3.8(0.65-19.3) 
Mother Received ARV     
    Yes 16(84.2) 1 141(93.4) 1 
    No  3(15.8) 2.2(1.7-5.32)   10(6.6) 3.1(0.72-8.21) 
EID done at 6weeks     
    Yes  8(42.1) 1 108(71.5) 1 
    No 11(57.9) 2.5(2.0-18.93) 43(28.5) 0.1(0.06-1.85) 
Received Infant 
Prophylaxis 
    
   Yes 13(68.4) 1 141(93.4) 1 
    No 6 (31.6) 1.7(1.5-15.42)   10(6.6) 2.0(0.79-10.34) 
Type of Prophylaxis 
received 
    
    NVP daily for 6weeks 10(76.9) 1 145(96.0) 1 
    Others  3 (23.1) 3.0(2.9 – 12.74)    6(4.0) 1.5(0.7 -9.9) 
 
 
Socio-demographic and Health predictors of 
outcomes of exposed infants: Table 5 shows 
the predictors of outcomes of exposed infants. 
The predictors for infants to be HIV infected 
were mothers who were aged ≥30years, mothers 
with vaginal tear during delivery, maternal CD4 
count < 500, infants who did not have EID done 
at 6 weeks, infants who received ARV 
prophylaxis other than daily Nevirapine for 6 
weeks with HIV.  
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Age(years)     
< 30 5(26.4) 1 48(31.8) 1 




Gestational age(weeks)     
  < 36    3(15.8) 1   25(16.7) 1 
   ≥36   16(84.2) 0.7 (0.6 -4.74) 126(83.3) 4.6(0.60-23.2) 
Parity     
   < 2 6 (31.6) 1 53(35.3) 1 
   ≥ 2 13(68.4) 1.2(0.1-5.52) 98(64.7) 2.0(1.40-
13.71) 
Birth weight (Kg)      
    < 2.5 2(10.5) 1 12(8.0) 1 
    ≥ 2.5 17(89.5) 1.1(0.11-3.52) 139(92.0) 0.2(0.11-4.71) 
Maternal CD4 Count     
   ≥  500 14(64.3) 1 141(93.4) 1 
   <500 5(35.7) 3.5(1.7-15.02) 10(6.6) 3.1(0.72-8.21) 
Received Infant 
Prophylaxis 
    
   Yes 10(53.6) 1   11(6.7) 1 
    No  9(46.4) 1.7(0.9-15.42)   140(93.3) 0.5(0.21-0.92) 
Type of Prophylaxis 
received 
    
    NVP daily for   
6weeks 
8(80.0) 1 145(96.0) 1 





This study described the outcomes of exposed 
infants of HIV positive mothers and the 
predictors of this outcome. Our study revealed 
that the positivity rate of HIV among HIV-
exposed infants in selected primary healthcare in 
Oyo state was 11.1%, which means one in ten 
exposed infants had positive status. This is still a 
burden to our society. A similar result was 
reported in Kano, Nigeria (18), Ibadan (19) and   
Zambia (20). However, a contrary result was 
reported from Nigeria in 2014 (21). This 
difference may be the result of different study 
settings and region of the country and the 
difference in the methodology and sample size 
of the two studies.  Although this study was 
conducted in primary healthcare centers, it 
reiterates the fact that pediatric HIV infection is 
still a significant public health issue in Nigeria, 
and the figures indicate a need for more 
preventive efforts in combating the disease. 
This study showed that mothers in the 
higher age group (≥ 30 years) were more likely 
to have infants who will acquire HIV infection; 
however, maternal age did not predict infants’ 
HIV status. A similar study by Akinsanya et al 
in a primary healthcare center in South Africa 
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had shown that maternal age greater than 
21 years was the only significant risk factor 
associated with MTCT (22).  
HIV is transmitted sexually when infected 
fluids encounter mucous membranes. Cuts or 
sores will increase the risk of transmission, but 
the risk is there without cuts, tears, or sores. The 
mucous membranes of the vagina experience a 
considerable amount of microtrauma (small tears 
in the vaginal wall that are not visible to the 
naked eye) during sex, and this microtrauma 
likely increases the probability of HIV 
transmission. The findings from this study 
showed that there is risk of HIV infection among 
infants whose mothers had vaginal tear during 
delivery even though no previous study has 
documented clear evidence on this. 
Low maternal CD4 count was associated 
with risk of acquiring HIV infection in this 
study. This finding is similar with the result of a 
study conducted by Akinsanya et al in South 
Africa. A study conducted among exposed 
infants in Zimbabwe concluded that there was 
no effect of maternal CD4+ T-cell count on 
exposed infant morbidity and mortality (23). 
However, maternal CD4 cell count less than 200 
cells/µl as in other studies has been associated 
with increased risk of all-cause infant sick clinic 
visits in the first year of life as cited by Athena 
et al. (24), possibly due to the mother’s poorer 
health and inability to care for the infant, or 
other factors such as length of infant exposure to 
mother’s pathogens or immunologic 
abnormalities in the HIV-exposed infants. 
Interestingly, a study conducted among 
European newborns of mothers with high and 
low CD4 counts concluded that mothers with 
high CD4 counts (> 500 cells/µl) that had taken 
sdNVP had significantly increased white blood 
cell, monocyte and basophil counts compared to 
newborn infants of mothers with similar CD4 
counts that had not taken sdNVP; this was not 
evident in infants of mothers with CD4 counts 
<200 cells/µl. The outcome justifies the 
commencement of antiretroviral therapy (ART) 
in HIV-infected pregnant women with low CD4 
count. This finding is in tandem with what 
previous research has shown: the lower the CD4 
count of the mother, the higher the rate of 
vertical transmission of HIV infection. Although 
the risk was low for vertical transmission of HIV 
when maternal CD4 count is above 500, there is 
still a chance of MTCT.  
The national guideline says that all exposed 
infants whose mothers are on ART should 
receive daily NVP from birth (or as soon as 
possible thereafter) until 6 weeks of age. All 
breastfeeding exposed infants whose mothers are 
not on ART should receive daily NVP from 
birth (or as soon as possible thereafter) until 1 
week after all exposure to breast milk has ended. 
A cross-sectional study among exposed infants 
in rural Uganda reported that infants who did not 
receive any form of prophylaxis were nine times 
more likely to be HIV positive (25) which is in 
line with the findings of this study. 
In conclusion, the level of HIV infection 
among HEIs in primary health care centres in 
Oyo state remains high. Low Maternal CD4 
count, age of mothers, vagina tear and early 
infant diagnosis not done in the first 6 weeks 
were predictors for acquiring HIV infection 
among the study population. Adequate attention 
should be paid to care of exposed infants 
especially at the PHC levels. Continuous 
placement of HIV positive mothers and exposed 
infants on prophylaxis and timely initiation of 
ART will go a long way in reducing the burden 
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